We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current KRON market cap is 61.55M. The company's latest EPS is USD -1.8673 and P/E is -0.55.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 918k | 2.29M | 2.52M | 2.69M | 2.37M |
| Operating Income | -33.82M | -27.34M | -31.99M | -18.02M | -15.72M |
| Net Income | -31.37M | -25.32M | -29.96M | -16.2M | -14.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 6.29M |
| Operating Income | -16.82M | -58.04M | -151.4M | -137.12M | -121.83M |
| Net Income | -16.12M | -88.44M | -151.08M | -133.2M | -112.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 237.99M | 213.28M | 182.98M | 164.27M | 150.02M |
| Total Liabilities | 59.37M | 54.2M | 46.01M | 41.13M | 38.9M |
| Total Equity | 178.62M | 159.08M | 136.97M | 123.15M | 111.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 102.69M | 511.96M | 391.48M | 294.94M | 213.28M |
| Total Liabilities | 2.98M | 46.45M | 46.38M | 50.44M | 54.2M |
| Total Equity | -23.2M | 465.52M | 345.1M | 244.5M | 159.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -53.56M | -78.58M | -23.9M | -40.23M | -52.6M |
| Investing | 34.81M | 66.37M | 5.77M | 45.95M | 63.08M |
| Financing | 376k | 567k | N/A | 164k | 163k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.08M | -37.91M | -117.92M | -90.93M | -78.58M |
| Investing | -67.58M | -160.24M | 63.72M | -32.22M | 66.37M |
| Financing | 105.01M | 415.61M | 4.46M | 851k | 567k |
| Market Cap | 61.55M |
| Price to Earnings Ratio | -0.55 |
| Price to Sales Ratio | 9.79 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 60.34M |
| Average Volume (1 week) | 234.56k |
| Average Volume (1 Month) | 222k |
| 52 Week Change | -5.56% |
| 52 Week High | 1.60 |
| 52 Week Low | 0.69 |
| Spread (Intraday) | 0.09 (8.37%) |
| Company Name | Kronos Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.kronosbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
